Products for Research Use Only
RegisterLogin

Concizumab

CAT: 0804-HY-P99283-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99283-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia[1][2].
CAS Number
1312299-39-0
Product Name Alternative
NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody
UNSPSC
12352203
Target
Factor Xa
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/concizumab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Concizumab]
Molecular Weight
(146.28 kDa)
References & Citations
[1]Kjalke M, et al. Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses. J Thromb Haemost. 2021 Jul;19 (7) :1687-1696. |[2]Agersø H, et al. Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration. Eur J Pharm Sci. 2014 Jun 2;56:65-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
T77373-01Concizumab
GTR18333621-01Concizumab Antibody
CBA1042-01Concizumab Biosimilar
591765Concizumab (TFPI)
GTR18872336Concizumab ELISA Kit
A2337-01Concizumab (Anti-TFPI)
HY403026-01Research Grade Concizumab
047778TFPI (concizumab) discontinued
KBI1245KRIBIOLISA™ Concizumab ELISA
E55B0511Concizumab (Reference antibody)

Popular Products